IKS Health (Inventurus Knowledge Solutions Ltd) , a leading provider of administrative solutions for healthcare organizations and backed by Rekha Jhunjhunwala, has revealed the price band for its upcoming initial public offering (IPO).
The price has been set between ₹1,265 and ₹1,329 per equity share, with a face value of Re 1.
The ₹2,500 crore IPO is scheduled to open for subscription on Thursday, December 12, and will close on Monday, December 16.
Additionally, the company has set Wednesday, December 11, for the allocation of shares to anchor investors.
Through this IPO, iks health aims to attract investors to one of the fastest-growing sectors in the U.S. healthcare market, providing a promising opportunity to participate in the company’s growth journey.
Objectives of the IPO:
The IPO seeks to:
- Offer investors a stake in a high-growth segment of the U.S. healthcare industry.
- Strengthen the company’s financial position and support its plans for future expansion.
- Enhance its market presence and technological capabilities to better serve its clientele.
About IKS Health:
IKS Health specializes in providing administrative services to healthcare organizations, primarily in the United States. The company’s expertise includes revenue cycle management, practice management, and other operational solutions that streamline healthcare administration. This positions IKS Health as a key player in an essential and rapidly growing segment of the global healthcare industry.
